628
Participants
Start Date
October 13, 2016
Primary Completion Date
May 19, 2017
Study Completion Date
July 11, 2017
Live attenuated SA 14-14-2 Japanese Encephalitis vaccine
Single 0.5 mL dose of World Health Organization prequalified live, attenuated SA 14-14-2 JE vaccine manufactured by Chengdu Institute of Biological Products, Chengdu, China, administered by subcutaneous injection
Measles, mumps, rubella vaccine
Single 0.5 mL dose of live, attenuated measles-mumps-rubella vaccine (Schwarz measles virus, RIT 4385 mumps strain, and Wistar RA 27/3 rubella virus) manufactured by GlaxoSmithKline, Inc., administered by subcutaneous injection.
Research Institute for Tropical Medicine, Manila
Collaborators (2)
Research Institute for Tropical Medicine
OTHER_GOV
Syneos Health
OTHER
DFNet Research Inc.
OTHER
PATH
OTHER